INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)

CUSIP: 45773H409

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
66,777,963
Total 13F shares
13,600,161
Share change
+197,486
Total reported value
$22,159,691
Put/Call ratio
278%
Price per share
$1.63
Number of holders
105
Value change
+$51,992
Number of buys
49
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q1 2025

As of 31 Mar 2025, INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by 105 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,600,161 shares. The largest 10 holders included Deep Track Capital, LP, BlackRock, Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, Stonepine Capital Management, LLC, STATE STREET CORP, NORTHERN TRUST CORP, MORGAN STANLEY, and UBS Group AG. This page lists 105 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.